Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 5:08 AM
Ignite Modification Date:
2025-12-25 @ 5:08 AM
NCT ID:
NCT00619827
Eligibility Criteria:
Inclusion Criteria:
* Male or female outpatients 18-50 years old
* grass pollen rhinoconjunctivitis of at least 2 years.
* positive specific skin prick test and a specific IgE dosage level of at least 0.70 kU/L at screening.
* written consent
* a positive response to the baseline challenge test (RTSS reaches 7 at one time-point at least during baseline challenge)
Exclusion Criteria:
* Allergic rhino-conjunctivitis due to a co-sensitisation, likely to significantly change the symptoms of the subject throughout the study
* Asthma requiring treatment other than short-acting beta-2 inhaled agonists.
* Desensitisation treatment for grass pollen in the previous five years and current immunotherapy with another allergen.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
50 Years
Study:
NCT00619827
Study Brief:
Protocol Section:
NCT00619827